FFCP PHASE2:Hg19::chr1:173793515..173793551,-
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
| Short description: | p2@CENPL |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_2_at_CENPL_5end |
| Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
| Association with transcript: | -42bp_to_ENST00000460816_5end |
| EntrezGene: | CENPL |
| HGNC: | 17879 |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p2@CENPL |
|---|
0
5
10
15
20
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| cancer | 4.85e-44 | 235 |
| disease of cellular proliferation | 8.65e-43 | 239 |
| hematologic cancer | 6.05e-24 | 51 |
| immune system cancer | 6.05e-24 | 51 |
| organ system cancer | 9.96e-22 | 137 |
| cell type cancer | 8.97e-21 | 143 |
| leukemia | 8.98e-19 | 39 |
| myeloid leukemia | 2.58e-14 | 31 |
| carcinoma | 6.31e-14 | 106 |
| lymphoma | 2.26e-07 | 10 |
Showing 1 to 10 of 12 entries
